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P atterns of Melanoma in White, Brown, and Black Skin White people in the 1980s seek a brown ("tan") skin color-a hue that was recognized for centuries as the "skin of a peasant." In a national survey [1] of 1013 adults and 126 teenagers (12 to 17 years), which was 
conducted for the American Academy of Dermatology, over two­
thirds of those interviewed said that a tan makes them look health­
ier, and one-third actually "work at getting a tan." In fact, over 50 
years ago to be tanned was apparently lauded by Mark Twain who 
said, "Nearly all black and brown skins are beautiful, but a beautiful 
white skin is rare." Whether this is true is a subjective matter, but 
what is true is that to have been born with a brown or black skin is 
the best preventative for the development of malignant melanoma 
of the skin. People, regardless of race, can be divided into three 
constitutive skin colors: black, brown, and white. Brown skin is the 
color of all Asiatics but also the skin color of some Caucasoids (East 
Indians, people of the Middle East, and many Mediterranean peo­
ples such as Egyptians, Southern Italians, and Southern French). 
Constitutive skin color [2] is the basic skin color (white, brown, 
black) of areas unexposed to sunlight vis-a.-vis facultative skin color, 
melanin pigmentation that develops in sun-exposed areas (i.e., tan­
ning). 
What is curious and thought provoking is that the incidence of 
melanoma of the skin in brown- and black-skinned persons is one­
seventh or less that of those with white skins, and furthermore, 
melanomas arising in black skin are mostly on the lower legs and 
feet (soles) or fingernails (acral lentiginous melanoma) [3]. In 
white-skinned persons melanomas arise most frequently on the 
upper back (males and females) and lower legs, but not the soles. 
While the incidence and mortality of melanoma in brown- and 
black-skinned persons are low, there is an alarming problem in the 
white population of the world with dramatic increases in mortality 
[4]. This, of course, excludes the idea that these increases are related 
to more awareness and overdiagnosis in the white population. Mor­
tality rates of primary melanoma in white-skinned persons for sin­
gle years from 1975- 1982 are rising at the rate of 3% per year for 
males [4]. In males living in Connecticut, ages 30-49, primary 
melanoma is the second most prevalent of all cancers, the first being 
cancer of the testis [5]. Some 26,000 new melanomas of the skin are 
predicted in the United States for 1987 [6], and the yearly increase in 
incidence of melanoma of the skin in white persons is second to the 
rate of increase of cancer of the lung. An estimated 6,000 patients 
will die from metastatic melanoma in 1987 [6]. 
Increasing Mortality of Melanoma in Japan The reasons for 
this striking discrepancy of incidence of primary melanoma of the 
skin in whites vis-a.-vis brown and black people are not at all clear or 
simple. Something has been happening in Japan in the last few 
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years. Mortality rates of melanoma in Japan have increased almost 
linearly from 0.06/100,000 to 0.21/100,000 in 1980; again these 
are mortality rates, and mere case finding cannot be a factor in these 
figures. So the challenge of Japanese and United States scientists 
(biologists and physicians) is to compare malignant melanoma in 
Japan and the United States not only to generate some hypotheses 
and to stimulate new case-control studies, but also to initiate molec­
ular studies of the possible differences in the two populations using 
the high technology now available. 
Skin color alone cannot explain the differences in incidence and 
mortality in white and pigmented people. Genes control pigmenta­
tion [2], but genetic factors could also simultaneously affect other 
parameters: DNA repair, immune surveillance, oncogenes and anti­
oncogenes, etc. It is too simplistic to believe that the explanation for 
the relative immunity of brown- and black-skinned people is based 
solely on the presence of a better melanin density filter in the epi­
dermis (i.e., brown or black skin). There are some paradoxes. For 
example, black albinos (oculocutaneous albinos) living in Nigeria 
and exposed to high solar intensities and without any melanin den­
sity filter die before age 40 of metastasizing squamous cell carci­
noma [7]. But it is curious, if sunlight has a role in its pathogenesis, 
that melanoma of the skin is rare indeed in these Nigerian albinos. 
Solar Radiation Exposure and Melanoma UVB is a known 
photocarcinogen, and there is general agreement in the United 
States that the more than 400,000 new patients each year with basal 
and squamous cell carcinoma are, for the most part, the result of 
exposure to UVB in sunlight. There is also increasing concern that 
the alarming and as yet unexplained increase in incidence since 
World War II of primary malignant melanoma of the skin in white 
people around the world is related in some degree to increasing 
exposure to solar radiation [8]. 
The data implicating sunlight and ultraviolet radiation (UVR) in 
the pathogenesis of melanoma are now quite convincing. The pop­
ulation at risk for melanoma of the skin in white persons includes 
several factors that implicate UVR [9]. 1) Persons with an inability 
to tan (Skin Phototypes I and II) are at risk [10]. In a case-control 
study from Australia, of 511 melanomas and 511 matched controls, 
"inability to tan" was the most important pigmentary trait as a risk 
factor in the patients with melanoma. The strongest risk factor was 
the number of palpable melanocytic nevi on a subject's arms [10]. 2) 
A history of a painful sunburn in adolescence indicates risk [11]. 3) 
There is a higher incidence in young indoor professional workers 
who obtain intermittent intense exposures ("weekenders" and 
"short trippers" who take winter vacations under a tropical sun). 4) 
Immunosuppressed (renal transplant) patients develop melanoma 
on exposed areas [12]. 5) Persons with the familial dysplastic mel a­
nocytic nevus syndrome are at high risk [13]. Inasmuch as there is no 
animal model in which melanoma has been elicited by exposure to 
UVB, we are not really certain that UVB is the action spectra in­
volved. However, there is a human model in the disease, xeroderma 
pigmentosum, in which these persons are genetically deficient in 
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repamng DNA UVB-induced damage and have significantly 
higher rates of melanoma and other UV -induced skin cancers than 
the general population; there is a 200-fold increase of primary mela­
noma of the skin by the age of 20 in patients with xeroderma 
pigmentosum [14]. Japanese patients with xeroderma pigmentosum 
have less melanoma than white patients [14]; this could be related to 
less sun exposure in the Japanese or, more probably, to a different 
susceptibility in white patients based on molecular mechanisms. 
A recent two-year intensive study reviewing the available infor­
mation on melanoma and skin cancer was carried out by a United 
States Environmental Protection Agency team of epidemiologists, 
statisticians, etc. [15]. Their conclusions were that exposure to solar 
radiation, and UVB in particular, is a likely cause of melanoma of 
the skin. In well-designed ecologic studies there is a correlation of a) 
higher melanoma incidence with decreasing latitudes and increas­
ing UVB levels, b) differences in the incidence of melanoma be­
tween native populations and immigrants to sunny climates (Israel, 
California), and c) sun exposure at early ages and the development 
of melanoma in adult life. Sun exposure between the ages of 10-15 
is a major risk factor. 
If UVB has an important role in melanoma, the dose response is 
complicated. This may be determined not only by the nature of 
UVB dose (i.e., intermittent high intensity vs continuous low in­
tensity), but the existence of a precursor pigmented lesion, the 
Clark' dysplastic melanocytic nevus, which is present is more than 
1 % of the white United States population, and in 90% of patients 
with familial melanoma and 50% of the blood (1st degree) relatives 
(siblings, parents, and children) of patients with familial melanoma 
[13]. Even in sporadic melanoma Clark's dysplastic melanocytic 
nevi are present in 30% of the patients. 
New Comparative Studies of Melanoma in the United States 
and Japanese Populations The important task for the future will 
be an educational program sponsored by the Japanese government 
and Japanese industrial concerns to alert the Japanese to the nature 
of melanoma and the hazards of sun exposure. This could possibly 
prevent in Japan the type of epidemic of melanoma of the skin that 
has occurred in the United States in the post World War II period. 
Japan, in fact, currently has (1987) about the same rates of mela­
noma of the skin as those reported by McDonald in the United 
States 40 years ago (1947) [16] (1.6/100,000 in males and 
2.0/100,000 in females). The increase in incidence in the United 
States since World War II is over 700%. 
Some new studies are needed to answer the question of why 
Asiatics are relatively resistant to the development of melanoma of 
the skin. Those studies should include 1) clinical epidemiologic 
studies of the Skin Phototype of Japanese people, 2) clinical epi­
demiologic studies of the incidence of Clark's dysplastic melanocy­
tic nevus in the Japanese, 3) clinical epidemiologic studies of the life 
style of Japanese people in 1960 compared to 1988 (trips to the 
beach, charter flights to sunny areas such as Hawaii and Guam), 4) 
comparison of DNA repair in Japanese and United States popula­
tions, 5) comparison of immune surveillance in the Japanese and 
United States populations, and 6) studies of anti-oncogenes on 
chromosome 3 in Japanese vs United States patients with mela­
noma. 
What is also needed is a United States-Japan Melanoma Study 
Commission comprised of epidemiologists, dermatologists, sur­
geons, pathologists, and biologists jointly funded by the United 
States and Japan, under the sponsorship of government, industry, 
and charitable foundations, to explore the important change in the 
incidence of melanoma occurring in the Japanese population. Such a 
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United States-Japan Melanoma Study Commission would require 
about three years to initiate both clinical and epidemiologic studies, 
as outlined above. Something that can be done immediately is to 
initiate an intensive educational program in Japan to alert the J apa­
nese people of the worrisome trend of the increased incidence of 
melanoma in Japan and alert them to the fact that a possible cause of 
this is more exposure to the sun in Japan in the summer and trips to 
the sunny climates in the winter. Malignant melanoma is one of the 
diseases in which poverty is protective [17]; the price of affluence in 
Japan in the last two decades may be an increased incidence of 
melanoma. A plausible explanation for this change in incidence is an 
increased number of hours of recreational sun exposure. 
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